Product Information

ENOXAPARIN 300 MG/3 ML VIAL is a generic product labeled by BluePoint Laboratories, priced at $10.7238 per ML under NDC 68001064141. Its NADAC has been published 68 times since Aug 6, 2025.

FDA first approved this application on Jun 14, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENOXAPARIN 300 MG/3 ML VIAL

Enoxaparin Sodium
$10.7238per ML

Strength

300 mg/3mL

NDC

68001064141

Classification

Generic

Dosage Form

INJECTION

Route

INTRAVENOUS; SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

ENOXAPARIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA214856

FDA Approved

6/14/2022

TE Code

AB

On Market Since

5/1/2025

Pharmacological Classes

Heparin
Low-Molecular-Weight
Low Molecular Weight Heparin

Price Statistics

The NADAC for ENOXAPARIN 300 MG/3 ML VIAL has been published 68 times since Aug 6, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$10.7238 per ML
All-time high$11.6405 (Dec 10, 2025)
All-time low$9.8724 (Sep 23, 2026)
52-week high$11.6405
52-week low$9.8724
Median price$10.9742
Average price$10.7596
Largest weekly change+7.5% (Nov 18, 2026)
Weeks tracked68
Tracking sinceAug 6, 2025

Price History

1W

+7.5%

1M

+8.6%

3M

+4.5%

6M

+5.3%

1Y

-6.2%

3Y

N/A

5Y

N/A

All

-1.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ENOXAPARIN 300 MG/3 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 300 MG/3 ML VIAL, manufactured by BluePoint Laboratories, is $10.7238 per ML (NDC 68001064141), effective Nov 18, 2026.

How has the price of ENOXAPARIN 300 MG/3 ML VIAL changed over time?

Over the history we have for it, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has held within roughly two percent of its current level. It has been tracked across 68 weekly CMS publications since Aug 6, 2025.

What are the highest and lowest recorded NADAC prices for ENOXAPARIN 300 MG/3 ML VIAL?

Since Aug 6, 2025, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has ranged from a low of $9.8724 (Sep 23, 2026) to a high of $11.6405 (Dec 10, 2025), with a median of $10.9742 per ML.

Are there cheaper alternatives to ENOXAPARIN 300 MG/3 ML VIAL?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ENOXAPARIN 300 MG/3 ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures ENOXAPARIN 300 MG/3 ML VIAL?

ENOXAPARIN 300 MG/3 ML VIAL (NDC 68001064141) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.